eNeura (Baltimore, Maryland), a privately held medical technology company, reported that it received FDA clearance for its SpringTMS migraine treatment device. SpringTMS is available to patients for the acute treatment of pain associated with migraine headache with aura.

Three years ago, med-tech companies were bracing for a massive shakeup on the healthcare landscape. The medical device tax, the implementation of the Affordable Care Act and vanishing venture capital funding, were all topics that caused a great deal of anxiety for many in the space. Forget thriving in the space. Many just wanted to survive. Yet earlier this month, thriving in the medical device industry was the focus of the Southeastern Medical Device Association's annual conference held in Atlanta. In fact, the title of the conference was "Thriving During Healthcare Reform." With the landscape more clearly defined, medical device...